Valisure
New Haven, US · Founded 2015 · Delaware LLC · 4 known investors
Valisure is a private company that accepts investment from venture capital firms, family offices, and individual accredited investors.
Founders & leadership
AC

Adam Clark-JosephCo-founder
DL

David LightPresident
DG
David GortlerChief Medical Officer
WH

Wolfgang HinzDirector, Promoter
KK
Kaury KuceraChief Scientific Officer
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$3.8MraisedJul 2020 · 6 investors · Other Health CareRule 506(b)
▶$3.8MraisedJul 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Wolfgang HinzDirector, Promoter
- Adam Clark-JosephDirector, Promoter
- David LightExecutive Officer, Director, Promoter
- Kaury KuceraExecutive Officer
- Robert CunninghamPromoter
- Jirstrand AlexandraExecutive Officer, Promoter
- Offering amount
- $10M
- Amount sold
- $3.8M
- Minimum investment
- $40K
- First sale
- Jun 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedOct 2019 · 5 investors · Other Health CareRule 506(b)
▶$4.3MraisedOct 2019 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert CunninghamPromoter
- Kaury KuceraExecutive Officer
- David GortlerExecutive Officer, Promoter
- David LightExecutive Officer, Director, Promoter
- Wolfgang HinzDirector, Promoter
- Jirstrand AlexandraExecutive Officer, Promoter
- Adam Clark-JosephDirector, Promoter
- Offering amount
- $5M
- Amount sold
- $4.3M
- First sale
- Sep 2019
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$853.2KraisedApr 2019 · 10 investors · Other Health CareRule 506(b)
▶$853.2KraisedApr 2019 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David LightExecutive Officer, Director, Promoter
- David GortlerExecutive Officer, Promoter
- Wolfgang HinzDirector, Promoter
- Robert CunninghamPromoter
- Kaury KuceraExecutive Officer
- Adam Clark-JosephDirector, Promoter
- Offering amount
- $1M
- Amount sold
- $853.2K
- Minimum investment
- $10K
- First sale
- Mar 2019
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$1.8MraisedFeb 2019 · 22 investors · Other Health CareRule 506(b)
▶$1.8MraisedFeb 2019 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert CunninghamPromoter
- Adam Clark-JosephDirector, Promoter
- Wolfgang HinzDirector, Promoter
- David LightExecutive Officer, Director, Promoter
- David GortlerExecutive Officer, Promoter
- Kaury KuceraExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.8M
- Minimum investment
- $30K
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$1.2MraisedAug 2018 · 10 investors · Other Health CareRule 506(b)
▶$1.2MraisedAug 2018 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kaury KuceraExecutive Officer
- Robert CunninghamPromoter
- David GortlerExecutive Officer, Promoter
- Wolfgang HinzDirector, Promoter
- Adam Clark-JosephDirector, Promoter
- David LightExecutive Officer, Director, Promoter
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $30K
- First sale
- Apr 2018
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$680KraisedJan 2018 · 7 investors · Other Health CareRule 506(b)
▶$680KraisedJan 2018 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam Clark-JosephExecutive Officer, Director, Promoter
- David LightExecutive Officer, Director, Promoter
- Wolfgang HinzDirector, Promoter
- Offering amount
- $700K
- Amount sold
- $680K
- Minimum investment
- $20K
- Proceeds to insiders
- $1
- First sale
- Oct 2017
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- It’s About Time - FDA Calls Foul on Valisure | Drug & Device Lawdruganddevicelawblog.com · 2025
- Valisure Receives Strategic Fundingfinsmes.com · 2024
- New Haven-based Valisure names new CEO, announces ‘substantial investments’hartfordbusiness.com · 2024
- FDA scolds Valisure, which raised red flags over drug impuritiesstatnews.com · 2022
- A tiny pharmacy raises big doubts about our drugs – Chicago Tribunechicagotribune.com · 2019